Financial Contrast: QT Imaging (NASDAQ:QTI) and Helius Medical Technologies (NASDAQ:HSDT)

Helius Medical Technologies (NASDAQ:HSDTGet Free Report) and QT Imaging (NASDAQ:QTIGet Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, dividends and analyst recommendations.

Insider & Institutional Ownership

18.6% of Helius Medical Technologies shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 5.1% of Helius Medical Technologies shares are owned by insiders. Comparatively, 75.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Risk & Volatility

Helius Medical Technologies has a beta of 1.58, meaning that its stock price is 58% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.13, meaning that its stock price is 113% less volatile than the S&P 500.

Earnings and Valuation

This table compares Helius Medical Technologies and QT Imaging’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Helius Medical Technologies $640,000.00 4.61 -$8.85 million ($13.04) -0.08
QT Imaging N/A N/A -$4.03 million N/A N/A

QT Imaging has lower revenue, but higher earnings than Helius Medical Technologies.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Helius Medical Technologies and QT Imaging, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Helius Medical Technologies 0 0 1 0 3.00
QT Imaging 0 0 0 0 N/A

Helius Medical Technologies presently has a consensus target price of $24.00, indicating a potential upside of 2,309.64%. Given Helius Medical Technologies’ higher possible upside, equities analysts plainly believe Helius Medical Technologies is more favorable than QT Imaging.

Profitability

This table compares Helius Medical Technologies and QT Imaging’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Helius Medical Technologies -1,328.14% -297.49% -107.36%
QT Imaging N/A N/A -19.75%

Summary

QT Imaging beats Helius Medical Technologies on 6 of the 10 factors compared between the two stocks.

About Helius Medical Technologies

(Get Free Report)

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

About QT Imaging

(Get Free Report)

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.